PulmCCM: Who It's For and Who Sponsors It

Covers: Clinical trials, medical guidelines, ICU drug therapies, critical care devices, and board preparation case questions.
For: Intensive care physicians, pulmonologists, and critical care medical professionals.
Best for: Critical care doctors seeking clinical trial updates and board study materials.
Skip if: General consumers and medical professionals outside of pulmonary and critical care.

Start with

Updated Guideline: Continuous infusions of beta-lactam antibiotics endorsed by SCCM, IDSA: Explains new clinical guidelines and trial data on continuous infusions of beta-lactam antibiotics.
Continuous renal replacement therapy saves lives over hemodialysis*: Reviews trial findings comparing continuous renal replacement therapy to hemodialysis for severe acute kidney injury.
Catheter-directed thrombolysis works for PE, without ultrasound: Analyzes clinical trial results for catheter-directed thrombolysis in intermediate-high-risk pulmonary embolism.

Summarised by AI from 12 recent issues. Audience size is not included. Prices are not included. Report a mistake.